The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils
NCT02140541 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130248
Last updated 2014-05-16
Summary
To explore the relationship between blood eosinophil counts, asthma exacerbations and patient asthma control using a large primary care based research database
Conditions
Sponsors & Collaborators
-
Teva Pharmaceuticals USA
collaborator INDUSTRY -
Research in Real-Life Ltd
lead NETWORK
Principal Investigators
-
David Price, Prof, MD · University of Aberdeen
Eligibility
- Min Age
- 12 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2014-07-31
- Completion
- 2014-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
REALL: A Retrospective Observational Study to Compare the Effectiveness and Cost-Effectiveness Between Different Step-3 Asthma Treatment Strategies
NCT00628563 ·Status: COMPLETED
-
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 ·Status: UNKNOWN
-
The Ohio State University Asthma Registry
NCT00839748 ·Status: WITHDRAWN
-
Asthma Exacerbation Study
NCT00853411 ·Status: WITHDRAWN ·Phase: NA
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up of Mild Eosinophilic Asthma
NCT04650503 ·Status: UNKNOWN
-
TNF Alpha in Refractory Asthma
NCT00276029 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
NCT04710134 ·Status: COMPLETED ·Phase: PHASE4
-
Asthma: Phenotyping Exacerbations 2
NCT04293445 ·Status: UNKNOWN
-
Retrospective Cohort Study on Asthma With Frequent Acute Attacks Phenotype
NCT06026462 ·Status: NOT_YET_RECRUITING
-
Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
NCT02452190 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma: Phenotyping Exacerbations 3
NCT05446090 ·Status: UNKNOWN
-
Epidemiology of Symptom Perception in Childhood Asthma
NCT00005461 ·Status: COMPLETED
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
Exploring Asthma Exacerbations in Mepolizumab Treated Patients
NCT03324230 ·Status: COMPLETED
-
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
NCT00112411 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
Asthma Biomarker Study
NCT02392481 ·Status: COMPLETED
-
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190 ·Status: COMPLETED
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Roflumilast Plus Montelukast in Adults With Severe Asthma
NCT01765192 ·Status: COMPLETED ·Phase: PHASE2
-
Intense Airway Eosinophilia in Asthma
NCT03696914 ·Status: COMPLETED
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications
NCT04185129 ·Status: UNKNOWN ·Phase: PHASE4